(Q28196661)

English

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

scientific article (publication date: May 2006)

In more languages

Statements

scholarly article

0 references

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease (English)

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

platelet aggregation

1 reference

based on heuristic

inferred from title

Agneta Siegbahn

8

object named as

Agneta Siegbahn

0 references

9

object named as

Lars Wallentin

0 references

1

object named as

Tomas Jernberg

0 references

5

object named as

John T Brandt

0 references

Joseph M Jakubowski

6

object named as

Joseph A Jakubowski

0 references

7

object named as

Hideo Naganuma

0 references

author name string

Christopher D Payne

2

0 references

Kenneth J Winters

3

0 references

Christelle Darstein

4

0 references

language of work or name

0 references

publication date

May 2006

0 references

European Heart Journal

0 references

27

0 references

10

0 references

1166-73

0 references

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI877

21 January 2018

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI877

21 January 2018

Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI877

21 January 2018

Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI877

21 January 2018

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI877

21 January 2018

Lipophilic statins interfere with the inhibitory effects of clopidogrel on platelet function — a flow cytometry study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI877

21 January 2018

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI877

21 January 2018

The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI877

21 January 2018

Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI877

21 January 2018

Durability of platelet inhibition by clopidogrel

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI877

21 January 2018

Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI877

21 January 2018

Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI877

21 January 2018

Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI877

21 January 2018

The difference between clopidogrel responsiveness and posttreatment platelet reactivity

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI877

21 January 2018

Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI877

21 January 2018

Controversies in antiplatelet therapy for patients with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI877

21 January 2018

Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI877

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28196661&oldid=2113681387"